BACKGROUND: Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary prevention after randomized, controlled trials demonstrating that they reduce the risk of death in patients with left ventricular systolic dysfunction. The extent to which the clinical characteristics and long-term outcomes of unselected, community-based patients with left ventricular systolic dysfunction undergoing primary prevention ICD implantation in a real-world setting compare with those enrolled in the randomized, controlled trials is not well characterized. This study is being conducted to address these questions. METHODS AND RESULTS: The study cohort includes consecutive patients undergoing primary prevention ICD placement between January 1, 2006 and December 31, 2009 in 7 health plans. Baseline clinical characteristics were acquired from the National Cardiovascular Data Registry ICD Registry. Longitudinal data collection is underway, and will include hospitalization, mortality, and resource use from standardized health plan data archives. Data regarding ICD therapies will be obtained through chart abstraction and adjudicated by a panel of experts in device therapy. Compared with the populations of primary prevention ICD therapy randomized, controlled trials, the cohort (n=2621) is on average significantly older (by 2.5-6.5 years), more often female, more often from racial and ethnic minority groups, and has a higher burden of coexisting conditions. The cohort is similar, however, to a national population undergoing primary prevention ICD placement. CONCLUSIONS: Patients undergoing primary prevention ICD implantation in this study differ from those enrolled in the randomized, controlled trials that established the efficacy of ICDs. Understanding a broad range of health outcomes, including ICD therapies, will provide patients, clinicians, and policy makers with contemporary data to inform decision-making.
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary prevention after randomized, controlled trials demonstrating that they reduce the risk of death in patients with left ventricular systolic dysfunction. The extent to which the clinical characteristics and long-term outcomes of unselected, community-based patients with left ventricular systolic dysfunction undergoing primary prevention ICD implantation in a real-world setting compare with those enrolled in the randomized, controlled trials is not well characterized. This study is being conducted to address these questions. METHODS AND RESULTS: The study cohort includes consecutive patients undergoing primary prevention ICD placement between January 1, 2006 and December 31, 2009 in 7 health plans. Baseline clinical characteristics were acquired from the National Cardiovascular Data Registry ICD Registry. Longitudinal data collection is underway, and will include hospitalization, mortality, and resource use from standardized health plan data archives. Data regarding ICD therapies will be obtained through chart abstraction and adjudicated by a panel of experts in device therapy. Compared with the populations of primary prevention ICD therapy randomized, controlled trials, the cohort (n=2621) is on average significantly older (by 2.5-6.5 years), more often female, more often from racial and ethnic minority groups, and has a higher burden of coexisting conditions. The cohort is similar, however, to a national population undergoing primary prevention ICD placement. CONCLUSIONS:Patients undergoing primary prevention ICD implantation in this study differ from those enrolled in the randomized, controlled trials that established the efficacy of ICDs. Understanding a broad range of health outcomes, including ICD therapies, will provide patients, clinicians, and policy makers with contemporary data to inform decision-making.
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy Journal: Circulation Date: 2008-05-15 Impact factor: 29.690
Authors: Sana M Al-Khatib; F Lee Lucas; James G Jollis; David J Malenka; David E Wennberg Journal: J Am Coll Cardiol Date: 2005-09-23 Impact factor: 24.094
Authors: James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss Journal: J Am Coll Cardiol Date: 2008-04-08 Impact factor: 24.094
Authors: Daniel B Mark; Kevin J Anstrom; Jie L Sun; Nancy E Clapp-Channing; Anastasios A Tsiatis; Linda Davidson-Ray; Kerry L Lee; Gust H Bardy Journal: N Engl J Med Date: 2008-09-04 Impact factor: 91.245
Authors: Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy Journal: N Engl J Med Date: 2008-09-04 Impact factor: 91.245
Authors: Wayne C Levy; Kerry L Lee; Anne S Hellkamp; Jeanne E Poole; Dariush Mozaffarian; David T Linker; Aldo P Maggioni; Inder Anand; Philip A Poole-Wilson; Daniel P Fishbein; George Johnson; Jill Anderson; Daniel B Mark; Gust H Bardy Journal: Circulation Date: 2009-08-24 Impact factor: 29.690
Authors: Lesley H Curtis; Sana M Al-Khatib; Alisa M Shea; Bradley G Hammill; Adrian F Hernandez; Kevin A Schulman Journal: JAMA Date: 2007-10-03 Impact factor: 56.272
Authors: Pamela N Peterson; Stacie L Daugherty; Yongfei Wang; Humberto J Vidaillet; Paul A Heidenreich; Jeptha P Curtis; Frederick A Masoudi Journal: Circulation Date: 2009-02-16 Impact factor: 29.690
Authors: Alexandra M Hajduk; Jerry H Gurwitz; Grace Tabada; Frederick A Masoudi; David J Magid; Robert T Greenlee; Sue Hee Sung; Andrea E Cassidy-Bushrow; Taylor I Liu; Kristi Reynolds; David H Smith; Frances Fiocchi; Robert Goldberg; Thomas M Gill; Nigel Gupta; Pamela N Peterson; Claudio Schuger; Humberto Vidaillet; Stephen C Hammill; Heather Allore; Alan S Go Journal: J Am Geriatr Soc Date: 2019-03-20 Impact factor: 5.562
Authors: Nisha Bansal; Adam Szpiro; Frederick Masoudi; Robert T Greenlee; David H Smith; David J Magid; Jerry H Gurwitz; Kristi Reynolds; Grace H Tabada; Sue Hee Sung; Ashveena Dighe; Andrea Cassidy-Bushrow; Romel Garcia-Montilla; Stephen Hammill; John Hayes; Alan Kadish; Param Sharma; Paul Varosy; Humberto Vidaillet; Alan S Go Journal: Heart Date: 2016-10-14 Impact factor: 5.994
Authors: Sean D Pokorney; Anne S Hellkamp; Clyde W Yancy; Lesley H Curtis; Stephen C Hammill; Eric D Peterson; Frederick A Masoudi; Deepak L Bhatt; Hussein R Al-Khalidi; Paul A Heidenreich; Kevin J Anstrom; Gregg C Fonarow; Sana M Al-Khatib Journal: Circ Arrhythm Electrophysiol Date: 2014-12-12
Authors: Ariel R Green; Amy Jenkins; Frederick A Masoudi; David J Magid; Jean S Kutner; Bruce Leff; Daniel D Matlock Journal: Pacing Clin Electrophysiol Date: 2016-09-22 Impact factor: 1.976
Authors: Benjamin A Steinberg; Sana M Al-Khatib; Rex Edwards; JooYoon Han; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Arthur J Moss; Kerry L Lee; Richard Steinman; Paul Dorian; Alfred Hallstrom; Riccardo Cappato; Alan H Kadish; Peter J Kudenchuk; Daniel B Mark; Lurdes Y T Inoue; Gillian D Sanders Journal: JACC Heart Fail Date: 2014-10-08 Impact factor: 12.035
Authors: Christopher E Knoepke; Larry A Allen; Karen Sepucha; Frederick A Masoudi; Jean Kutner; Paul Varosy; David Magid; Daniel D Matlock Journal: Pacing Clin Electrophysiol Date: 2021-02-19 Impact factor: 1.976
Authors: Frederick A Masoudi; Alan S Go; David J Magid; Andrea E Cassidy-Bushrow; Jerry H Gurwitz; Taylor I Liu; Kristi Reynolds; David H Smith; Liza M Reifler; Karen A Glenn; Frances Fiocchi; Robert Goldberg; Nigel Gupta; Pamela N Peterson; Claudio Schuger; Humberto Vidaillet; Stephen C Hammill; Robert T Greenlee Journal: J Am Heart Assoc Date: 2015-06-02 Impact factor: 5.501
Authors: Pamela N Peterson; Robert T Greenlee; Alan S Go; David J Magid; Andrea Cassidy-Bushrow; Romel Garcia-Montilla; Karen A Glenn; Jerry H Gurwitz; Stephen C Hammill; John Hayes; Alan Kadish; Kristi Reynolds; Param Sharma; David H Smith; Paul D Varosy; Humberto Vidaillet; Chan X Zeng; Sharon-Lise T Normand; Frederick A Masoudi Journal: J Am Heart Assoc Date: 2017-11-09 Impact factor: 5.501